Format

Send to

Choose Destination
Semin Cancer Biol. 2004 Jun;14(3):181-5.

Chemokines in neoplastic progression.

Author information

1
Neurocrine Biosciences, 10555 Science Center Drive, San Diego, CA 92121, USA. azlotnik@neurocrine.com

Abstract

Chemokines and their receptors have emerged as attractive targets regulating the migration of tumor cells in vivo, a process known as cancer metastasis. The control of metastasis is critical to the control of cancer progression. Two chemokine receptors and their ligands stand out as likely targets for therapeutics: CCR7/CCL21 for lymph node metastases, and CXCR4/CXCL12 for lung, liver, bone marrow, and brain metastases. The most widely expressed chemokine receptor among cancers is likely to be CXCR4.

PMID:
15246053
DOI:
10.1016/j.semcancer.2003.10.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center